2021 annual financial data
Atea Pharmaceuticals 2021 Revenue growth
Direct answer
Revenue growth was 622.49%.
Operating income was 138,377,000 USD and net income was 121,190,000 USD.
Operating cash flow was -87,005,000 USD.
Get free Atea Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 351,367,000 USD
- Operating income
- 138,377,000 USD
- Net income
- 121,190,000 USD
- Operating cash flow
- -87,005,000 USD